SEC Form 3 · accession 0001415889-19-000081
Exactus, Inc. · EXDI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin James Esval
Director
Period of report
Jan 11, 2019
Accepted (ET)
Jan 17, 2019 · 5:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552189
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 2,000 | D | ||
| Common Stock | holding | — | — | — | 3,400,000 | I | 1,900,000 shares held by VelocityHealth Capital; 1,500,000 shares held by Donegal Bio Ventures |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $0.025 | holding | — | — | — | Jan 11, 2019 | Jan 11, 2029 | Common Stock | 2,000,000 | — | D |
| Series B-2 Preferred Stock | $0.00 | holding | — | — | — | Jan 11, 2019 | Jan 17, 2050 | Common Stock | 168,000 | — | I |